Principales conclusions et analyse des parts de marché des anticorps monoclonaux contre le cancer d'ici 2025-2031
Cancer Monoclonal Antibodies Market Report Analysis
Cancer Monoclonal Antibodies Market
-
CAGR (2025 - 2031)18% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Amgen Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Johnson and Johnson Services, Inc.
- Novartis AG
- Eli Lilly and Company
- Spectrum Pharmaceuticals, Inc.
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Type
- anticorps murins
- anticorps chimériques
- anticorps humanisés
By Thérapies
- Bevacizumab
- Rituximab
- Trastuzumab
- Cetuximab
- Panitumumab
- Autres thérapies par anticorps monoclonaux
By Application
- cancer du sein
- cancer du sang
- cancer du foie
- cancer du cerveau
- cancer colorectal
- cancer du poumon
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Get Free Sample For